Sensus Healthcare, Inc.

How big is Sensus Healthcare, Inc.?

As of Jun 18, Sensus Healthcare, Inc. has a market capitalization of 79.64 million, with net sales of 39.49 million and a net profit of 1.81 million over the latest four quarters. The balance sheet shows shareholder's funds of 55.83 million and total assets of 62.19 million.

As of Jun 18, Sensus Healthcare, Inc. has a market capitalization of 79.64 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 39.49 million for the latest four quarters, alongside a net profit of 1.81 million during the same period.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds amounting to 55.83 million and total assets of 62.19 million.

What does Sensus Healthcare, Inc. do?

Sensus Healthcare, Inc. is a medical device company specializing in non-invasive treatments for skin conditions, with recent net sales of $8 million and a market cap of $79.64 million. The company reported a net profit of -$3 million for the quarter ending March 2025.

Overview: <BR>Sensus Healthcare, Inc. is a medical device company focused on providing non-invasive treatments for both oncological and non-oncological skin conditions, operating within the Pharmaceuticals & Biotechnology industry and categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 8 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -3 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 79.64 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 45.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.35 <BR>Return on Equity: 3.40% <BR>Price to Book: 1.50<BR><BR>Contact Details: <BR>Address: 851 Broken Sound Pkwy NW Ste 215, BOCA RATON FL: 33487-3635 <BR>Tel: ['1 561 9225808', '1 212 8383777'] <BR>Fax: 1 561 9482071 <BR>Website: https://sensushealthcare.com/

Should I buy, sell or hold Sensus Healthcare, Inc.?

Who are in the management team of Sensus Healthcare, Inc.?

As of March 2022, the management team of Sensus Healthcare, Inc. includes Chairman and CEO Joseph Sardano, Directors Megan Cornish and Anthony Petrelli, and Non-Executive Independent Directors John Heinrich, William McCall, and Samuel O'Rear. They are responsible for the company's strategic direction and operations.

As of March 2022, the management team of Sensus Healthcare, Inc. includes the following individuals:<BR><BR>- Mr. Joseph Sardano: Chairman of the Board, President, Chief Executive Officer, Co-Founder<BR>- Ms. Megan Cornish: Director<BR>- Mr. Anthony Petrelli: Non-Employee Director<BR>- Dr. John Heinrich: Non-Executive Independent Director<BR>- Mr. William McCall: Non-Executive Independent Director<BR>- Mr. Samuel O'Rear: Non-Executive Independent Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

Is Sensus Healthcare, Inc. overvalued or undervalued?

As of August 7, 2025, Sensus Healthcare, Inc. is considered risky and overvalued due to its high P/E ratio of 45 and EV to EBITDA of 20.70, which are significantly higher than its peers like Kewaunee Scientific Corp., while its low ROCE of 7.47% and ROE of 3.40% do not justify its valuation.

As of 7 August 2025, the valuation grade for Sensus Healthcare, Inc. has moved from expensive to risky, indicating a shift in perception regarding its market position. The company appears to be overvalued, given its high P/E ratio of 45 compared to peers and industry standards. Additionally, the EV to EBITDA ratio stands at 20.70, which is significantly higher than Kewaunee Scientific Corp.'s attractive EV to EBITDA of 8.2820, further emphasizing the relative overvaluation of Sensus.<BR><BR>With a ROCE of 7.47% and a ROE of 3.40%, Sensus Healthcare's financial performance does not justify its current valuation metrics. The peer comparison shows that while Sensus is categorized as risky, other companies like Kewaunee Scientific Corp. are considered attractive, highlighting the disparity in valuation. Although return data is not available for a direct comparison with the S&P 500, the current valuation metrics suggest that Sensus Healthcare, Inc. is not positioned favorably in the market.

Is Sensus Healthcare, Inc. technically bullish or bearish?

As of August 8, 2025, Sensus Healthcare, Inc. is in a bearish trend, supported by bearish MACD, Bollinger Bands, and moving averages, with mixed signals from other indicators.

As of 8 August 2025, the technical trend for Sensus Healthcare, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from multiple indicators. The MACD is bearish on both the weekly and monthly time frames, and Bollinger Bands also confirm a bearish outlook for both periods. Daily moving averages are bearish, and the KST is bearish on the weekly and mildly bearish on the monthly. The Dow Theory shows a mildly bullish signal on the weekly but no trend on the monthly, while the OBV is mildly bearish on the weekly. There is no available return data to compare the company's performance against the S&P 500.